Fujian Cosunter Pharmaceutical Co., Ltd. Obtains Approval for Setup of Academician Expert Workstation
The Academician Expert Workstation of Fujian Cosunter Pharmaceutical Co., Ltd. has been honored with the title"Fujian Provincial Academician Expert Workstation",becoming one of the 23 newly established provincial academician expert workstations across Fujian.
Disclosure of Cosunter’s Environmental Influence Assessment Report for Its Synthetic Drug Technology Renovation Project
Cosunter has engaged an EIA institution to prepare the Environmental Influence Assessment Report for Cosunter’s Synthetic Drug Technology Renovation Project.
Strategic Cooperation Agreement signed by Cosunter and Sinopharm Group
Both parties hope to share all strategic resources by intercommunication on the basis of separated purchasing negotiated and relying on third-party logistics and multiple-warehouse operation for the win-win purpose.
Clinical Data Collected over Three Years from TDF-ETV Non-inferiority Control Trial by Cosunter First Released Globally at APASL Annual Meeting 2017
The 26th Conference of the Asian Pacific Association for the Study of the Liver (APASL) was held at Shanghai International Convention Center on February 15 - 19, 2017 in Shanghai, China.
Strategic Cooperation Framework Agreement Signed by Cosunter and WuXi AppTec for “the Best Plan of HBV Treatment”
Cosunter cooperated with WuXi AppTec regarding the project related to HBV treatment method independently developed by Cosunter for the purpose of “the Best Plan of HBV Treatment”. The Strategic Cooperation Framework Agreement was signed by both parties on February 9, 2017.
Second Disclosure of Cosunter’s Environmental Influence Assessment for Its Synthetic Drug Technology Renovation Project
Cosunter has engaged an EIA institution to prepare the Environmental Influence Assessment Report for Cosunter’s Synthetic Drug Technology Renovation Project (simplified edition). We disclose the preliminary conclusion of this EIA for the project to the public according to the Law of the People's Republic of China on Appraising of Environment and the Temporary Methods of Public Consultation for EIA.
2015 Environmental Information Disclosure of Fujian Cosunter Pharmaceutical Co., Ltd.
Fujian Cosunter Pharmaceutical Co., Ltd. is located in the Fuyuan Industrial Park, Zherong County, Ningde City. Zherong County (27°05′N-27°19′N, 119°43′E-120°04′E) is in the northeast of Fujian
“Realizing China Dream: A Visit to Listed Company” - Open Day Activities of Cosunter’s Investors
The “fairness is around us” special investor protection activities jointly sponsored by the China Securities Regulatory Commission Investor Protection Bureau, China Securities Investor Protection Fund Corporation and China Securities Medium and Small Investor Service Center were officially launched in the middle of 2015. On August 28, in cooperation with China Insurance Regulatory Commission Fujian Bureau and Listed Companies Association of Fujian
Fujian Cosunter Pharmaceutical--The Fifth "Challenge Yourself ▪ Embrace the Future" Scholarship
Challenge yourself and you will be a better person; embrace the future and you will have a promising tomorrow. On August 22, the "Challenge Yourself ▪ Embrace the Future" scholarship and grant ceremony of Fujian Cosunter Pharmaceutical Co., Ltd. was successfully held in Zherong First High School, Ningde City. This event won strong support and affirmation from the local government and the education department.
Speech by the Chairman of Fujian Cosunter Pharmaceutical Co., Ltd.
Today, April 22, 2015, we are listed in Shenzhen Stock Exchange. Fujian Cosunter Pharmaceutical Co., Ltd., the first company in Ningde, Fujian listed in the said exchange, is a young modern pharmaceutical enterprise.